13 September 2021
Latham & Watkins Advises Itamar Medical in Acquisition by ZOLL Medical
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hans Brigham Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Max Schleusener Lead | Latham & Watkins LLP | Partner | corporate | Chicago |
| Ariel Cho | Latham & Watkins LLP | Associate | corporate | Not stated |
| Nathan Ajiashvili | Latham & Watkins LLP | Partner | capital markets | New York |
| Joshua Kiernan | Latham & Watkins LLP | Partner | capital markets | London |
| Michael Rosenberg | Latham & Watkins LLP | Counsel | capital markets | New York |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | FDA regulatory | Bay Area |
| Judith Hasko | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Jiqiang Lin | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Elena Romanova | Latham & Watkins LLP | Partner | tax | New York |
| Shruti Hazra | Latham & Watkins LLP | Associate | tax | Not stated |
| Matthew Conway | Latham & Watkins LLP | Partner | benefits and compensation | Washington, D.C. |
| Ashlie Lawton | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Héctor Armengod | Latham & Watkins LLP | Partner | antitrust | Brussels |
| Ian Conner | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Patrick English | Latham & Watkins LLP | Counsel | antitrust | Washington, D.C. |
| Damara Chambers | Latham & Watkins LLP | Partner | CFIUS | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Counsel | data privacy and security | Bay Area |
Stated terms
- Stated value
- USD 538m (approximately US$538 million)
- What the figure measures
- Total transaction value
- Client
- Itamar MedicalSell-side
- Counterparties
- ZOLL Medical Corporation (Buy-side)